S&P 500   2,925.47 (-1.79%)
DOW   25,284.78 (-1.87%)
QQQ   202.07 (-1.74%)
AAPL   261.47 (-4.41%)
FB   186.54 (-1.69%)
MSFT   156.01 (-1.38%)
GOOGL   1,296.60 (-1.40%)
AMZN   1,843.56 (-2.16%)
CGC   18.18 (-1.41%)
NVDA   250.26 (-0.93%)
BABA   202.32 (-1.32%)
MU   49.86 (-1.42%)
GE   10.18 (-2.02%)
TSLA   635.91 (-6.35%)
AMD   42.63 (-3.14%)
T   34.93 (-2.24%)
ACB   1.39 (-4.14%)
F   6.84 (-1.87%)
NFLX   373.73 (+0.54%)
PRI   111.73 (-2.66%)
BAC   28.54 (-2.03%)
DIS   116.09 (-1.65%)
GILD   70.68 (-2.73%)
S&P 500   2,925.47 (-1.79%)
DOW   25,284.78 (-1.87%)
QQQ   202.07 (-1.74%)
AAPL   261.47 (-4.41%)
FB   186.54 (-1.69%)
MSFT   156.01 (-1.38%)
GOOGL   1,296.60 (-1.40%)
AMZN   1,843.56 (-2.16%)
CGC   18.18 (-1.41%)
NVDA   250.26 (-0.93%)
BABA   202.32 (-1.32%)
MU   49.86 (-1.42%)
GE   10.18 (-2.02%)
TSLA   635.91 (-6.35%)
AMD   42.63 (-3.14%)
T   34.93 (-2.24%)
ACB   1.39 (-4.14%)
F   6.84 (-1.87%)
NFLX   373.73 (+0.54%)
PRI   111.73 (-2.66%)
BAC   28.54 (-2.03%)
DIS   116.09 (-1.65%)
GILD   70.68 (-2.73%)
S&P 500   2,925.47 (-1.79%)
DOW   25,284.78 (-1.87%)
QQQ   202.07 (-1.74%)
AAPL   261.47 (-4.41%)
FB   186.54 (-1.69%)
MSFT   156.01 (-1.38%)
GOOGL   1,296.60 (-1.40%)
AMZN   1,843.56 (-2.16%)
CGC   18.18 (-1.41%)
NVDA   250.26 (-0.93%)
BABA   202.32 (-1.32%)
MU   49.86 (-1.42%)
GE   10.18 (-2.02%)
TSLA   635.91 (-6.35%)
AMD   42.63 (-3.14%)
T   34.93 (-2.24%)
ACB   1.39 (-4.14%)
F   6.84 (-1.87%)
NFLX   373.73 (+0.54%)
PRI   111.73 (-2.66%)
BAC   28.54 (-2.03%)
DIS   116.09 (-1.65%)
GILD   70.68 (-2.73%)
S&P 500   2,925.47 (-1.79%)
DOW   25,284.78 (-1.87%)
QQQ   202.07 (-1.74%)
AAPL   261.47 (-4.41%)
FB   186.54 (-1.69%)
MSFT   156.01 (-1.38%)
GOOGL   1,296.60 (-1.40%)
AMZN   1,843.56 (-2.16%)
CGC   18.18 (-1.41%)
NVDA   250.26 (-0.93%)
BABA   202.32 (-1.32%)
MU   49.86 (-1.42%)
GE   10.18 (-2.02%)
TSLA   635.91 (-6.35%)
AMD   42.63 (-3.14%)
T   34.93 (-2.24%)
ACB   1.39 (-4.14%)
F   6.84 (-1.87%)
NFLX   373.73 (+0.54%)
PRI   111.73 (-2.66%)
BAC   28.54 (-2.03%)
DIS   116.09 (-1.65%)
GILD   70.68 (-2.73%)
Log in

NASDAQ:IRTC - Irhythm Technologies Stock Price, Forecast & News

$83.17
+2.77 (+3.45 %)
(As of 02/28/2020 09:41 AM ET)
Today's Range
$75.78
Now: $83.17
$83.17
50-Day Range
$70.58
MA: $85.33
$89.80
52-Week Range
$56.24
Now: $83.17
$98.07
Volume41,548 shs
Average Volume235,764 shs
Market Capitalization$2.21 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.6
iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$147.29 million
Book Value$2.25 per share

Profitability

Net Income$-48,280,000.00

Miscellaneous

Employees748
Market Cap$2.21 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.


Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) announced its earnings results on Thursday, February, 27th. The company reported ($0.65) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.12. The firm earned $59.10 million during the quarter, compared to analyst estimates of $58.42 million. Irhythm Technologies had a negative return on equity of 67.44% and a negative net margin of 26.45%. The business's quarterly revenue was up 41.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.61) earnings per share. View Irhythm Technologies' Earnings History.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Irhythm Technologies.

What guidance has Irhythm Technologies issued on next quarter's earnings?

Irhythm Technologies issued an update on its FY 2020 After-Hours earnings guidance on Thursday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $280-290 million, compared to the consensus revenue estimate of $283.61 million.

What price target have analysts set for IRTC?

7 Wall Street analysts have issued 12 month price targets for Irhythm Technologies' shares. Their forecasts range from $90.00 to $125.00. On average, they expect Irhythm Technologies' stock price to reach $106.80 in the next year. This suggests a possible upside of 28.4% from the stock's current price. View Analyst Price Targets for Irhythm Technologies.

What is the consensus analysts' recommendation for Irhythm Technologies?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Irhythm Technologies.

Has Irhythm Technologies been receiving favorable news coverage?

Press coverage about IRTC stock has been trending very negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Irhythm Technologies earned a media sentiment score of -3.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Irhythm Technologies.

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Twilio (TWLO), Tandem Diabetes Care (TNDM), Alibaba Group (BABA), Canopy Growth (CGC), NVIDIA (NVDA), Paypal (PYPL), Paycom Software (PAYC), DexCom (DXCM), Splunk (SPLK) and Square (SQ).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the folowing people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are Irhythm Technologies' major shareholders?

Irhythm Technologies' stock is owned by many different of retail and institutional investors. Top institutional investors include Capital Research Global Investors (7.91%), William Blair Investment Management LLC (4.64%), Alliancebernstein L.P. (3.38%), Franklin Resources Inc. (2.56%), State Street Corp (2.53%) and Victory Capital Management Inc. (1.86%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Raymond W Scott and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Technologies.

Which major investors are selling Irhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Partner Fund Management L.P., Franklin Resources Inc., Lord Abbett & CO. LLC, Sectoral Asset Management Inc, Goldman Sachs Group Inc., Fiera Capital Corp, Man Group plc and First Trust Advisors LP. Company insiders that have sold Irhythm Technologies company stock in the last year include David A Vort, Kevin M King, Matthew C Garrett and Merz Cathleen Noel Bairey. View Insider Buying and Selling for Irhythm Technologies.

Which major investors are buying Irhythm Technologies stock?

IRTC stock was bought by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Renaissance Technologies LLC, Capital Research Global Investors, Alliancebernstein L.P., Victory Capital Management Inc., State Street Corp, Victory Capital Management Inc. and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Irhythm Technologies.

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $83.17.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $2.21 billion and generates $147.29 million in revenue each year. The company earns $-48,280,000.00 in net income (profit) each year or ($1.89) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.View Additional Information About Irhythm Technologies.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is http://www.irhythmtech.com/.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]


MarketBeat Community Rating for Irhythm Technologies (NASDAQ IRTC)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  218 (Vote Underperform)
Total Votes:  501
MarketBeat's community ratings are surveys of what our community members think about Irhythm Technologies and other stocks. Vote "Outperform" if you believe IRTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: P/E Growth (PEG)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel